Join Andreas Weinhausel from the Austrian Institute of Technology (AIT) and learn about the role of biomarkers in the clinical diagnosis and therapeutic treatment of rheumatoid arthritis.
Antibodies and autoantibodies make suitable biomarkers for the prediction and monitoring of disease. Sero-testing of plasma or serum is minimally invasive, and immunomics analysis has great potential for the diagnostics of autoimmune, cancerous, cardiologic, neurodegenerative, and systemic conditions.
Andreas is a biotechnologist and associate professor for molecular biology at the University of Natural Resources and Applied Life Sciences, Vienna. He has been at the Molecular Diagnostics business unit at AIT since 2004, specialising in DNA-methylation and autoantibody biomarker development high throughput technologies. This new workflow combines microarray and bead array technologies for biomarker development. Probing antigenic proteins and peptides, the platform offers a powerful solution for diagnosing cancer and autoimmune disease.